Target Validation

Our target protein candidates are first-in-class entities discovered via our proprietary predictive discovery platforms. Therefore, following the in silico discovery process, our novel targets are relayed to a therapeutically focused validation process, which is performed in-house as well as via scientific collaborations with top academic laboratories. Promising validated targets are then advanced in our mAb therapeutics pipeline.

Therapeutically focused target validation overview of immune checkpoints



Max 1mb, accepted formats: pdf, doc, docx, rtf
[recaptcha size:compact]
Message Sent. Thank You!